Live and non-live pregnancy outcomes among women with depression and anxiety: A population-based study

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ban, Lu ^a   Tata, Laila J ^a   West, Joe ^a,b   Fiaschi, Linda ^a   Gibson, Jack E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE; ANTENATAL DEPRESSION; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OBESITY; PERINATAL DEATH; POPULATION BASED CASE CONTROL STUDY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL DRUG EXPOSURE; RISK ASSESSMENT; SIDE EFFECT; SMOKING; SOCIAL STATUS; SPONTANEOUS ABORTION; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 84866630544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043462     Document Type: Article

References (41)

1. Cooper WO, Willy ME, Pont SJ, Ray WA, (2007) Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196 (6):: 544.e1-544.e5.
2. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, et al. (2008) Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198 (2):: 194.e1-194.e5.
3. Udechuku A, Nguyen T, Hill R, Szego K, (2010) Antidepressants in pregnancy: a systematic review. Aust N Z J Psychiatry 44 (11):: 978-996.
4. Klieger-Grossmann C, Weitzner B, Panchaud A, Pistelli A, Einarson T, et al. (2012) Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J Clin Pharmacol 52 (5):: 766-770.
5. Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, et al. (2008) Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66 (5):: 695-705.
6. Nakhai-Pour HR, Broy P, Bérard A, (2010) Use of antidepressants during pregnancy and the risk of spontaneous abortion 182 (10):: 1031-1037.
7. Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, et al. (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192 (3):: 932-936.
8. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, et al. (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269 (17):: 2246-2248.
9. Einarson A, Choi J, Einarson TR, Koren G, (2009) Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can 31 (5):: 452-456.
10. Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, et al. (2006) Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 194 (4):: 961-966.
11. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL, (1993) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (14):: 1010-1015.
12. Santone G, Ricchi G, Rocchetti D, Tofani S, Bellantuono C, (2009) Is the exposure to antidepressant drugs in early pregnancy a risk factor for spontaneous abortion? A review of available evidences. Epidemiol Psichiatr Soc 18 (3):: 240-247.
13. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, et al. (2004) Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 49 (11):: 726-735.
14. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O, (2000) Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 95 (4):: 487-490.
15. Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, et al. (2002) Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol 155 (4):: 293-301.
16. Hanlon C, Medhin G, Alem A, Tesfaye F, Lakew Z, et al. (2009) Impact of antenatal common mental disorders upon perinatal outcomes in Ethiopia: the P-MaMiE population-based cohort study. Trop Med Int Health 14 (2):: 156-166.
17. Zhu S-H, Valbø A, (2002) Depression and smoking during pregnancy. Addict Behav 27 (4):: 649-658.
18. Clark DA, Arck PC, Jalali R, Merali FS, Manuel J, et al. (1996) Psycho-neuro-cytokine/endocrine pathways in immunoregulation during pregnancy. Am J Reprod Immunol 35 (4):: 330-337.
19. Rondo PHC, Ferreira RF, Nogueira F, Ribeiro MCN, Lobert H, et al. (2003) Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur J Clin Nutr 57 (2):: 266-272.
20. Lennestål R, Källén B, (2007) Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 27 (6):: 607-613.
21. Wikner BN, Stiller C, Bergman U, Asker C, Källén B, (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiology and Drug Safety 16 (11):: 1203-1210.
22. Ornoy A, Arnon J, Shechtman S, Moerman L, Lukashova I, (1998) Is benzodiazepine use during pregnancy really teratogenic? Reproductive Toxicology 12 (5):: 511-515.
23. Laegreid L, Hagberg G, Lundberg A, (1992) The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 23 (1):: 18-23.
24. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL, (2007) Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16 (4):: 393-401.
25. British Medical Association, Royal Pharmaceutical Society of Great Britain (2009) British national formulary: 57th ed. Pharmaceutical Press.
26. Morris R, Carstairs V, (1991) Which deprivation? A comparison of selected deprivation indexes. J Public Health Med 13 (4):: 318-326.
27. Swann C, Bowe K, McCormick G, Kosmin M (2003) Teenage pregnancy and parenthood: a review of reviews. London: DHA. Available: http://www.nice.org.uk/niceMedia/documents/teenpreg_evidence_briefing_su mmary.pdf.
28. Coste J, Job-Spira N, Fernandez H, (1991) Risk factors for spontaneous abortion: a case-control study in France. Human Reproduction 6 (9):: 1332-1337.
29. Blackmore ER, Côté-Arsenault D, Tang W, Glover V, Evans J, et al. (2011) Previous prenatal loss as a predictor of perinatal depression and anxiety. Br J Psychiatry 198: 373-378.
30. Office for National Statistics. Birth statistics, England and Wales (Series FM1) (2009) Available: http://www.ons.gov.uk/ons/rel/vsob1/birth-statistics-england-and-wales-s eries-fm1-/no-37-2008/index.html. Accessed 2011 Nov 14.
31. NHS Direct Wales. Miscarriage. Available: http://www.nhsdirect.wales.nhs.uk/encyclopaedia/m/article/miscarriage/. Accessed 2011 Nov 14.
32. Department of Health. Abortion Statistics, England and Wales: 2008. (2009) Available: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publicati onsStatistics/DH_099285. Accessed 2011 Nov 14.
33. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, et al. (1998) Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279 (8):: 609-610.
34. Einarson A, Bonari L, Voyer-Lavigne S, Addis A, Matsui D, et al. (2003) A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry 48 (2):: 106-110.
35. Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, et al. (2001) Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 158 (10):: 1728-1730.
36. Hemels MEH, Einarson A, Koren G, Lanctôt KL, Einarson TR, (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39 (5):: 803-809.
37. Hartz SC, Heinonen OP, Shapiro S, Siskind V, Slone D, (1975) Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N Engl J Med 292 (14):: 726-728.
38. Milkovich L, van den Berg BJ, (1974) Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 291 (24):: 1268-1271.
39. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, et al. (2011) Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 22 (6):: 848-854.
40. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, et al. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (5):: 499-507.
41. Einarson A, Selby P, Koren G, (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 26 (1):: 44-48.